Open AccessP941: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM‐6 ARM‐A INTERIM ANALYSIS
Author(s) -
Quach H.,
Gironella M.,
Lee C.,
Popat R.,
Cannell P.,
Kasinathan R. S.,
Chopra B.,
Rogers R.,
FerronBrady G.,
ShafiHarji S.,
Patel N.,
Opalinska J.,
Gupta I.,
Augustson B.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846632.03623.af
Subject(s) - lenalidomide , medicine , tolerability , dexamethasone , interim analysis , adverse effect , refractory (planetary science) , clinical trial , physics , astrobiology